Oropouche virus disease
Oropouche virus disease clinical and global spread profile: 12 countries, 13 WHO outbreak events since 2016.
Oropouche virus disease · ICD-10 A930 · ICD-11 1D43 · 13 WHO events across 12 countries (2016–2024).
Top affected countries
| Country | Region | Events | % of global |
|---|---|---|---|
| Peru | AMR | 2 | 15% |
| Cuba | AMR | 1 | 8% |
| Bolivia (Plurinational State of) | AMR | 1 | 8% |
| French Guiana | — | 1 | 8% |
| United States of America | AMR | 1 | 8% |
| Brazil | AMR | 1 | 8% |
| Canada | AMR | 1 | 8% |
| Colombia | AMR | 1 | 8% |
| Ecuador | AMR | 1 | 8% |
| Guyana | AMR | 1 | 8% |
| Cayman Islands | — | 1 | 8% |
| Panama | AMR | 1 | 8% |
Annual outbreak timeline
| Year | Events | Countries |
|---|---|---|
| 2024 | 11 | 11 |
| 2020 | 1 | 1 |
| 2016 | 1 | 1 |
Peak year: 2024 (11 events).
Decade summary
| Decade | Events |
|---|---|
| 2010s | 1 |
| 2020s | 12 |
WHO case definition
A disease caused by an infection with Oropouche virus. This disease is characterised by fever, headache, neck and back pain, joint pain, or photophobia. This disease may also present with bronchitis, nausea, diarrhoea, abdominal pain or burning sensations all over the body. Transmission is through the bite of an infected mosquito or midge. Confirmation is by detection of the Oropouche virus specific antibodies in a serum sample.
Countries Affected
12
Outbreak Events
13
Year Range
2016–2024
ICD-10 A930
Oropouche virus disease
Visualization
Global Prevalence Snapshot
Based on WHO Disease Outbreak News events (2016–2024).
Risk Level
Continue exploring
